Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Judith Shlay

Concepts (244)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sexually Transmitted Diseases
11
2020
166
2.250
Why?
Text Messaging
7
2022
182
2.160
Why?
School Health Services
7
2015
224
2.100
Why?
Sexual Health
6
2022
66
2.070
Why?
Immunization Programs
6
2015
194
1.940
Why?
Pregnancy in Adolescence
4
2017
84
1.460
Why?
Safety-net Providers
2
2020
125
1.120
Why?
Opioid-Related Disorders
3
2022
600
1.100
Why?
Sexual Behavior
10
2022
491
0.980
Why?
Influenza Vaccines
4
2015
529
0.980
Why?
Condoms
5
2016
101
0.970
Why?
Stereotyping
1
2026
47
0.940
Why?
Health Promotion
4
2026
774
0.930
Why?
Reimbursement Mechanisms
3
2015
80
0.900
Why?
Colorado
16
2026
4564
0.810
Why?
Social Stigma
1
2026
171
0.800
Why?
Insurance, Health, Reimbursement
2
2014
96
0.790
Why?
Language
1
2026
321
0.760
Why?
Ambulatory Care Facilities
5
2013
265
0.760
Why?
Pregnancy, Unwanted
3
2009
15
0.710
Why?
Electronic Health Records
3
2026
1173
0.690
Why?
Attitude to Health
2
2014
436
0.660
Why?
Body Composition
7
2010
706
0.660
Why?
Analgesics, Opioid
4
2022
1143
0.650
Why?
Family Planning Services
2
2013
94
0.650
Why?
Contraception Behavior
2
2016
107
0.620
Why?
Substance-Related Disorders
2
2026
1094
0.610
Why?
HIV Infections
13
2026
3154
0.610
Why?
Contraception
5
2022
169
0.580
Why?
Papillomavirus Infections
6
2013
345
0.580
Why?
Patient Participation
2
2019
431
0.540
Why?
Influenza, Human
2
2014
616
0.540
Why?
Parental Consent
2
2014
25
0.520
Why?
Reverse Transcriptase Inhibitors
2
2008
87
0.520
Why?
Anti-HIV Agents
4
2009
888
0.500
Why?
Opiate Substitution Treatment
1
2019
187
0.490
Why?
Sex Education
1
2016
34
0.480
Why?
Adolescent
26
2026
22428
0.480
Why?
Papanicolaou Test
4
2013
35
0.470
Why?
Vaginal Smears
4
2013
55
0.460
Why?
Parents
2
2014
1403
0.450
Why?
Adolescent Health Services
1
2015
75
0.430
Why?
Minority Health
1
2014
18
0.420
Why?
Female
48
2026
78271
0.410
Why?
Financing, Government
1
2014
53
0.410
Why?
Social Values
1
2014
40
0.410
Why?
Patient Protection and Affordable Care Act
1
2014
102
0.400
Why?
Adult
34
2026
40449
0.390
Why?
Delivery of Health Care
3
2022
947
0.380
Why?
Pregnancy
15
2026
7190
0.370
Why?
Health Care Costs
2
2014
427
0.360
Why?
Humans
53
2026
144759
0.360
Why?
Geographic Information Systems
1
2011
46
0.350
Why?
Male
31
2026
72315
0.340
Why?
Tumor Virus Infections
1
2011
49
0.340
Why?
Stavudine
2
2008
6
0.340
Why?
Dideoxynucleosides
2
2008
22
0.330
Why?
Lamivudine
2
2008
65
0.330
Why?
Subcutaneous Fat
3
2010
78
0.300
Why?
Social Support
1
2014
652
0.300
Why?
Vaccines
1
2014
389
0.290
Why?
Anti-Retroviral Agents
4
2013
250
0.280
Why?
Public Health
1
2013
566
0.270
Why?
Zidovudine
1
2008
77
0.270
Why?
Vaccination
3
2013
1423
0.270
Why?
Insurance, Health
3
2015
302
0.260
Why?
HIV Protease Inhibitors
1
2007
69
0.250
Why?
Costs and Cost Analysis
2
2020
219
0.250
Why?
Health Status
1
2011
836
0.240
Why?
Program Evaluation
4
2026
948
0.230
Why?
Indians, North American
1
2011
647
0.220
Why?
Patient Compliance
1
2009
588
0.220
Why?
Primary Health Care
2
2014
1733
0.220
Why?
Papillomavirus Vaccines
3
2013
297
0.220
Why?
Respiratory Syncytial Virus, Human
1
2026
81
0.220
Why?
Natural Language Processing
1
2026
103
0.220
Why?
Antiretroviral Therapy, Highly Active
5
2010
278
0.220
Why?
Focus Groups
3
2026
573
0.210
Why?
Middle Aged
20
2019
35875
0.210
Why?
Risk Assessment
3
2013
3671
0.210
Why?
Respiratory Syncytial Virus Infections
1
2026
136
0.210
Why?
Attitude of Health Personnel
1
2012
1185
0.210
Why?
Pregnancy Complications, Infectious
2
2026
428
0.210
Why?
Health Knowledge, Attitudes, Practice
3
2026
1414
0.210
Why?
Community-Institutional Relations
2
2015
101
0.210
Why?
Physicians
1
2012
939
0.200
Why?
Diagnostic Errors
1
2005
175
0.200
Why?
HIV-1
4
2011
896
0.190
Why?
Pelvic Inflammatory Disease
1
2022
12
0.180
Why?
Follow-Up Studies
6
2017
5408
0.180
Why?
Intrauterine Devices
1
2022
29
0.180
Why?
Reproductive Health
1
2022
91
0.180
Why?
Long-Acting Reversible Contraception
1
2022
34
0.170
Why?
Human papillomavirus 16
2
2011
27
0.170
Why?
United States
9
2020
15966
0.170
Why?
Patient Acceptance of Health Care
3
2014
885
0.160
Why?
Heroin
1
2020
29
0.150
Why?
Allied Health Personnel
1
2020
55
0.150
Why?
Cardiovascular Diseases
1
2011
2168
0.150
Why?
Incidence
4
2013
2879
0.150
Why?
Prevalence
5
2013
2834
0.140
Why?
Multivariate Analysis
4
2009
1539
0.140
Why?
Drug Prescriptions
1
2020
284
0.140
Why?
HIV-Associated Lipodystrophy Syndrome
2
2010
11
0.130
Why?
Inpatients
1
2022
545
0.130
Why?
Lipids
3
2009
710
0.130
Why?
Uterine Cervical Neoplasms
2
2013
267
0.130
Why?
Young Adult
6
2026
14105
0.130
Why?
Cost-Benefit Analysis
2
2013
634
0.120
Why?
Adipose Tissue
4
2010
652
0.120
Why?
Child
5
2019
22633
0.120
Why?
Reminder Systems
1
2017
141
0.120
Why?
Medicaid
1
2020
461
0.120
Why?
Organizational Case Studies
1
2015
69
0.110
Why?
Drug Overdose
1
2020
370
0.110
Why?
Women's Health
2
2009
310
0.110
Why?
Inflammation
1
2026
2878
0.110
Why?
Health Plan Implementation
1
2015
136
0.100
Why?
Direct Service Costs
1
2014
7
0.100
Why?
Immunization Schedule
1
2015
187
0.100
Why?
Machine Learning
1
2020
585
0.100
Why?
Cervix Uteri
2
2011
50
0.100
Why?
National Health Programs
1
2013
23
0.100
Why?
AIDS Dementia Complex
1
2013
52
0.100
Why?
Sex Counseling
2
2003
4
0.100
Why?
Models, Immunological
1
2013
100
0.100
Why?
Research Design
1
2019
1135
0.100
Why?
Cross-Sectional Studies
6
2013
5868
0.090
Why?
Emergency Medical Services
1
2020
696
0.090
Why?
Clinical Trials as Topic
1
2017
1053
0.090
Why?
Health Services Needs and Demand
1
2014
280
0.090
Why?
Mass Screening
2
2013
1347
0.090
Why?
Uterine Cervical Dysplasia
2
2011
27
0.090
Why?
Medroxyprogesterone Acetate
1
2011
37
0.090
Why?
Time Factors
4
2013
7173
0.090
Why?
Human papillomavirus 18
1
2011
12
0.090
Why?
Schools
1
2014
453
0.080
Why?
Contraceptive Agents, Female
1
2011
80
0.080
Why?
Protease Inhibitors
1
2011
102
0.080
Why?
Self Efficacy
1
2014
414
0.080
Why?
Urban Population
2
2004
491
0.080
Why?
Chi-Square Distribution
1
2011
529
0.080
Why?
Hospitalization
1
2020
2433
0.080
Why?
Long QT Syndrome
1
2011
69
0.080
Why?
Regression Analysis
2
2009
1003
0.080
Why?
Health Education
1
2013
358
0.080
Why?
Risk-Taking
2
2002
328
0.070
Why?
Life Style
1
2011
479
0.070
Why?
Learning
1
2013
452
0.070
Why?
Ambulatory Care
1
2013
600
0.070
Why?
Neuropsychological Tests
1
2013
1134
0.070
Why?
Pilot Projects
1
2014
1886
0.070
Why?
Virology
1
2008
36
0.070
Why?
Cohort Studies
4
2008
5960
0.070
Why?
Odds Ratio
1
2009
1075
0.060
Why?
Osteoporosis
1
2009
236
0.060
Why?
Aged
6
2011
25913
0.060
Why?
Bone Density
1
2009
482
0.060
Why?
Risk Factors
5
2011
10779
0.060
Why?
Didanosine
1
2005
13
0.060
Why?
Practice Guidelines as Topic
1
2013
1560
0.060
Why?
Genital Diseases, Female
1
2005
31
0.050
Why?
Socioeconomic Factors
1
2009
1326
0.050
Why?
Vaginosis, Bacterial
1
2004
10
0.050
Why?
Prospective Studies
2
2009
7990
0.050
Why?
Community-Based Participatory Research
1
2026
166
0.050
Why?
Urban Health Services
1
2004
70
0.050
Why?
Abortion, Therapeutic
1
2003
3
0.050
Why?
Spermatocidal Agents
1
2003
7
0.050
Why?
CD4 Lymphocyte Count
3
2010
277
0.050
Why?
Fetal Blood
1
2026
342
0.050
Why?
Pregnancy Rate
1
2003
69
0.050
Why?
Catheters, Indwelling
1
2003
96
0.050
Why?
Killer Cells, Natural
1
2026
467
0.050
Why?
Randomized Controlled Trials as Topic
2
2015
1720
0.050
Why?
Hysterectomy
1
2003
137
0.050
Why?
Dendritic Cells
1
2026
499
0.050
Why?
Community Health Centers
1
2002
59
0.040
Why?
Program Development
2
2015
370
0.040
Why?
Longitudinal Studies
1
2009
2947
0.040
Why?
Contraceptive Agents
1
2022
65
0.040
Why?
Risk
1
2004
911
0.040
Why?
Postoperative Care
1
2003
288
0.040
Why?
Forecasting
1
2002
391
0.040
Why?
Insulin Resistance
2
2009
1241
0.040
Why?
Papillomaviridae
2
2013
115
0.040
Why?
Blood Glucose
2
2009
2327
0.040
Why?
Counseling
1
2003
408
0.040
Why?
Sensitivity and Specificity
1
2005
1985
0.040
Why?
Immunity, Innate
1
2026
846
0.040
Why?
Child, Preschool
1
2014
11787
0.040
Why?
Logistic Models
1
2004
2117
0.040
Why?
Absorptiometry, Photon
2
2010
276
0.040
Why?
Proportional Hazards Models
1
2002
1325
0.040
Why?
Insulin
2
2009
2507
0.030
Why?
Referral and Consultation
1
2003
851
0.030
Why?
Predictive Value of Tests
1
2002
2115
0.030
Why?
Retrospective Studies
3
2022
17066
0.030
Why?
Viral Load
2
2011
526
0.030
Why?
Electric Impedance
2
2007
111
0.030
Why?
Automation
1
2015
102
0.030
Why?
Motivation
1
2020
610
0.030
Why?
Cell Phone
1
2015
82
0.030
Why?
Infant, Newborn
1
2026
6429
0.030
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
2013
13
0.020
Why?
Epidemiological Monitoring
1
2013
69
0.020
Why?
Data Collection
1
2015
633
0.020
Why?
Infant
1
2026
10034
0.020
Why?
Coitus
1
2011
23
0.020
Why?
Sentinel Surveillance
1
2011
46
0.020
Why?
Sex Factors
2
2008
2112
0.020
Why?
Electrocardiography, Ambulatory
1
2011
64
0.020
Why?
Subcutaneous Fat, Abdominal
1
2010
15
0.020
Why?
Needs Assessment
1
2013
404
0.020
Why?
Radionuclide Imaging
1
2010
112
0.020
Why?
Sexual Partners
1
2011
192
0.020
Why?
Health Behavior
1
2015
785
0.020
Why?
Hip Joint
1
2009
172
0.020
Why?
Adolescent Behavior
1
2013
501
0.020
Why?
Drug Administration Schedule
1
2009
779
0.020
Why?
Lumbar Vertebrae
1
2009
252
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2008
139
0.020
Why?
Dose-Response Relationship, Drug
1
2011
2027
0.020
Why?
Gastrointestinal Diseases
1
2008
216
0.010
Why?
Anthropometry
1
2005
200
0.010
Why?
Polymerase Chain Reaction
1
2008
1054
0.010
Why?
Liver Diseases
1
2008
304
0.010
Why?
Metronidazole
1
2004
20
0.010
Why?
Prognosis
1
2013
4282
0.010
Why?
Treatment Outcome
2
2011
11679
0.010
Why?
Verbal Behavior
1
2004
43
0.010
Why?
Fractures, Bone
1
2009
414
0.010
Why?
Infectious Disease Transmission, Vertical
1
2004
193
0.010
Why?
Device Removal
1
2003
143
0.010
Why?
Anti-Infective Agents
1
2004
242
0.010
Why?
RNA, Viral
1
2005
688
0.010
Why?
Recurrence
1
2004
1135
0.010
Why?
Evidence-Based Medicine
1
2004
732
0.010
Why?
Smoking
1
2007
1472
0.010
Why?
Surveys and Questionnaires
1
2013
6048
0.010
Why?
Age Factors
1
2007
3333
0.010
Why?
Tomography, X-Ray Computed
1
2009
2730
0.010
Why?
Body Mass Index
1
2007
2438
0.010
Why?
Pain
1
2003
779
0.010
Why?
Shlay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)